These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 28002979)

  • 21. Appropriate outpatient macrolide use in community-acquired pneumonia.
    Gotfried MH
    J Am Acad Nurse Pract; 2004 Apr; 16(4):146, 148, 150 passim. PubMed ID: 15137473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic therapy for inpatients with community-acquired pneumonia in a developing country.
    Trinh HT; Hoang PH; Cardona-Morrell M; Nguyen HT; Vu DH; Dong PT; Cao TT; Nguyen ST; Pham VT; Moss L; Dinh K; Dartnell J; Nguyen HT
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):129-36. PubMed ID: 24648269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children.
    Esposito S; Principi N
    Drug Resist Updat; 2002 Apr; 5(2):73-87. PubMed ID: 12135583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the impact of clinical recommendations on antibiotic use for CAP and HCAP: results from an implementation program in an Academic Hospital.
    Cattani G; Madia A; Arnoldo L; Brunelli L; Celotto D; Grillone L; Valent F; Castriotta L; Pea F; Bassetti M; Brusaferro S
    Ann Ig; 2020; 32(4):344-356. PubMed ID: 32744293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective.
    Farkas A; Sassine J; Mathew JP; Stavropoulos C; Stern R; Mckinley G
    J Antimicrob Chemother; 2018 Sep; 73(9):2555-2558. PubMed ID: 29897465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
    Kimura T; Ito M; Onozawa S
    J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.
    Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN
    Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance of pathogens causing community-acquired pneumonia.
    Feldman C; Anderson R
    Semin Respir Crit Care Med; 2012 Jun; 33(3):232-43. PubMed ID: 22718209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: A quasi-experimental study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Am J Infect Control; 2016 May; 44(5):e73-9. PubMed ID: 26899527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
    Segreti J; House HR; Siegel RE
    Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved management of community-acquired pneumonia in the emergency department.
    Julián-Jiménez A; Palomo de los Reyes MJ; Parejo Miguez R; Laín-Terés N; Cuena-Boy R; Lozano-Ancín A
    Arch Bronconeumol; 2013 Jun; 49(6):230-40. PubMed ID: 23477946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed?
    Cunha BA
    Chest; 2004 May; 125(5):1913-9. PubMed ID: 15136407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of community-acquired pneumonia in adults.
    Working Group of the South African Thoracic Society
    S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital.
    Bond SE; Boutlis CS; Yeo WW; Miyakis S
    Intern Med J; 2017 May; 47(5):582-585. PubMed ID: 28503879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.